Home
The Society
Membership
Meetings
2021 Virtual Symposium
More...
Franck Amblard, PhD
Emory University
Synthesis of Novel 2’-disubstituted Ribonucleoside Analogs
Leonid Beigelman, PhD
Aligos Therapeutics
Oligonucleotides Based Approaches for Treatment of Chronic Hepatitis B
Robert Britton, PhD
Simon Fraser University
A de novo Nucleoside Synthesis: New Opportunities for Medicinal and Process Chemistry
Joy Feng, PhD
Gilead Sciences, Inc.
Discovery of Remdesivir and Beyond
Krishna N. Ganesh, FNA, FASc, FTWAS
Indian Institute of Science Education and Research (IISER) Tirupati
PNAs with Double Face: Bimodal PNAs as Templates for Supramolecular Assemblies of Nucleic Acids
Kenneth A. Jacobson, PhD
National Institutes of Health
Design and Therapeutic Potential of Purinergic Receptor Ligands
Stephanie Kath-Schorr, PhD
University of Cologne
RNA Functionalization via an Expanded Genetic Alphabet
Maureen McKeague, PhD
McGill University
Ribozyme Gene Switches for Biosensing and Regeneration Studies
Ronald Micura, PhD
University of Innsbruck
A Natural Riboswitch Scaffold with Methyltransferase Activity
Prof. Barbara Nawrot
Polish Academy of Sciences
Novel DNA-boron Cluster Conjugates with Two Faces
Professor Satoshi Obika
Osaka University
Development of Sugar-modified Oligonucleotides with Higher Enzymatic Stability Than PS Oligonucleotides
Kelvin Ogilvie, PhD
Acadia University
Therapeutic Nucleosides and Evolution of Oligonucleotide Synthesis
Bradley L. Pentelute, PhD
MIT
Talk Title: Coming Soon
Prof Andrea Rentmeister
University of Münster
Jean-Pierre Sommadossi, PhD
Atea Pharmaceuticals
Rapidly Advancing Transformational Therapeutic Solutions for Patients with Severe Viral Diseases
Olalla Vázquez, PhD
Philipps-Universität Marburg
Mark K. Schlegel, PhD
Alnylam Pharmaceuticals
Improved Specificity of Conjugate siRNAs Through Chemical Modification
Marcus Wihelmsson, PhD
Chalmers University of Technology
Stealth Fluorescence Labeling for Live-Cell Imaging in RNA-based Therapeutics
